Sector portfolio · VC firm · United States
Viking Global's Biotech portfolio
Viking Global has backed 23 Biotech startups in rounds we track, $4.3B between them, shown by the stage each has reached. The best-funded is Bridgebio.
Funding by segment
- Stage not reported$1.9B7
- Series B$1.2B7
- Series C and later$1.2B5
- Series A$51M4
Where they are based
- United States22$4.1B
- Canada1$142M
United States
CanadaFounded
6 without a founding year on record.
Total raised
- Under $1M1
- $1M to $10M4
- $10M to $50M4
- $50M to $250M8
- $250M to $1B5
- $1B and over1
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
17 of 23 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States22
- Canada1
Startups by country, 2 countries in all.
Segment by segment
Stage not reported
7 startups · $1.9B raised
BridgeBioBridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers.United States$1.4B- AHAuris HealthUnited States$220M
Amylyx PharmaceuticalsAmylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain.United States$175M
Xcell BiosciencesXcell Biosciences is a next-generation development and manufacturing platform for enhanced cell therapy performance.United States$14M
Solarea BioSolarea Bio develops microbial therapeutics aimed to treat indications derived from chronic inflammation to aid human health.United States$9.9M
NextGen JaneNextGen Jane is a data-driven women's health company.United States$2.2M
Polaris GenomicsHarnessing genomics, we make invisible wounds like PTSD visible.United States$250K
Series B
7 startups · $1.2B raised
Editas MedicineEditas Medicine is a clinical-stage genome editing company that develops genomic medicines for serious diseases.United States$335M- VBViela BioViela Bio is a clinical-stage biotechnology company pioneering and advancing treatments for severe inflammation and autoimmune diseases.United States$325M
- CTCity TherapeuticsUnited States$235M
Abdera TherapeuticsAbdera Therapeutics is a precision oncology company based in South San Francisco, California, with an additional office in Vancouver, Canada.Canada$142M- EEdiosUnited States$64M
Locus BiosciencesLocus Biosciences develops CRISPR-engineered precision antibacterial platform designed to revolutionize the treatment of bacterial disease.United States$54M
DermBiontDermBiont is a biotech company that develops skin microbiome therapeutics to treat and prevent skin diseases.United States$43M
Series C and later
5 startups · $1.2B raised
Ginkgo BioworksZymergen is now a part of Ginkgo Bioworks!United States$444M- GBGingko BioworksUnited States$275M
SetPoint MedicalSetPoint Medical is a commercial-stage medical technology company founded in 2007, focused on developing bioelectronic therapies fUnited States$256M
Deciphera PharmaceuticalsDeciphera Pharmaceuticals focuses on improving kinase inhibitor treatments.United States$127M- PPPMV PharmaUnited States$62M
Series A
4 startups · $51M raised
AllonniaAllonnia is a Boston-based bio-ingenuity company founded in 2019, focusing on environmental biotechnology and engineering.United States$20M
Astarte MedicalAstarte Medical is a clinical intelligence company dedicated to precision medicine for preterm infants and children with medical complexity.United States$13M
Mantra BioMantra Bio, Inc.United States$9.0M
NextGen넥스트젠은 크리에이터 수익화 플랫폼입니다.United States$9.0M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Viking Global as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like Viking Global?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.